Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | - CEO | XSHE Exchange | CNE000001P94 ISIN |
China Country | 1,605 Employees | - Last Dividend | 10 Jun 2008 Last Split | - IPO Date |
Wanbangde Pharmaceutical Holding Group Co., Ltd., originally established in 1985 and headquartered in Taizhou City, China, has significantly evolved over the years. Initially known as Wanbangde New Building Materials Co., Ltd., the company underwent a notable transformation in April 2020 when it redirected its focus towards the pharmaceutical industry, consequently changing its name to better reflect its new orientation. Today, it is recognized for its comprehensive involvement in the research and development, production, and sale of various pharmaceutical products and medical equipment not just within China but on an international scale. The company’s operations are segmented into two main areas: Pharmaceutical Production and Sales, and Medical Equipment and Personal Equipment Production and Sale, catering to a broad spectrum of healthcare needs from medication to sophisticated medical devices.
Wanbangde Pharmaceutical Holding Group Co., Ltd. offers a wide range of products and services aimed at enhancing healthcare outcomes. These include: